Search
- Report
In September 2023, the last remaining investment made by the Treasury through the Troubled Asset Relief Program was repaid, thereby ending the program. CBO estimates that the government’s total subsidy cost was $31 billion.
- Report
CBO summarizes recent research findings about Medicare accountable care organizations and the factors that have contributed to or limited their ability to achieve net budgetary savings for the Medicare program.
- Report
Between 1980 and 2022, the shipbuilding composite index grew an average of 1.2 percentage points faster per year than the GDP deflator did. Looking ahead, a gap of roughly 1 percentage point would be consistent with historical experience.
- Interactive
This workbook allows users to define and analyze alternative economic scenarios by specifying differences in the values of four economic variables relative to the values underlying CBO's February 2024 projections.
- Report
The Subcommittee on Health of the House Committee on Energy and Commerce convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
The House Committee on the Budget convened a hearing at which Phillip L. Swagel, CBO's Director, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
CBO expects to be able to provide an estimated range of the budgetary effects of H.R. 1770, the Equitable Community Access to Pharmacist Services Act, by the end of June 2024.
- Presentation
Presentation by Noelia Duchovny, an analyst in CBO’s Health Analysis Division, at the National Academies’ Roundtable on Obesity Solutions.
- Presentation
Presentation by Chapin White, CBO’s Director of Health Analysis, at the David Rogers Health Policy Colloquium, Weill Cornell Medicine.
- Recurring Data
Extensions of 10-year economic projections for additional decades.